SEC Form 4 reporting owner

Collins Helen Louise

Collins Helen Louise has filed 33 Form 4 transactions reported between February 12, 2026 and September 17, 2026, as CHIEF MEDICAL OFFICER of Enliven Therapeutics, Inc. and a reporting owner of Kura Oncology, Inc..

Name as filed: Collins Helen Louise

Open-market buys, 24 mo
None
reported
Open-market sales, 24 mo
$1.5M
19 lines
Companies
2
with Form 4 filings
Latest transaction
Sep 17, 2026
transaction date

Roles and reported holdings

  • ELVNEnliven Therapeutics, Inc.
    Feb 12, 2026 – Sep 17, 2026

    CHIEF MEDICAL OFFICER

    Held directly25,000 sh as of Sep 17, 2026 · Form 4

    24 months: $1.5M sold

  • KURAKura Oncology, Inc.
    Jun 4, 2026

    Reporting owner

    No common-stock holding reported on a purchase, sale, gift or withholding line.

Transaction history

All 33 reported transactions, newest first. Every row links to the Form 4 on SEC EDGAR.

DateCompanyTypeSharesValueFiling
Sep 17, 2026ELVNCHIEF MEDICAL OFFICEROpen-market saleCode S · direct240$12K@ $51.48Form 4
Sep 17, 2026ELVNCHIEF MEDICAL OFFICEROpen-market saleCode S · direct1,844$94K@ $50.71Form 4
Sep 17, 2026ELVNCHIEF MEDICAL OFFICEROpen-market saleCode S · direct2,916$146K@ $50.03Form 4
Sep 17, 2026ELVNCHIEF MEDICAL OFFICEROption exerciseCode M · direct5,000$12K@ $2.48Form 4
Aug 17, 2026ELVNCHIEF MEDICAL OFFICEROpen-market saleCode S · direct1,100$65K@ $59.35Form 4
Aug 17, 2026ELVNCHIEF MEDICAL OFFICEROpen-market saleCode S · direct3,900$228K@ $58.37Form 4
Aug 17, 2026ELVNCHIEF MEDICAL OFFICEROption exerciseCode M · direct5,000$12K@ $2.48Form 4
Jul 17, 2026ELVNCHIEF MEDICAL OFFICEROpen-market saleCode S · direct63$3K@ $53.92Form 4
Jul 17, 2026ELVNCHIEF MEDICAL OFFICEROpen-market saleCode S · direct2,184$117K@ $53.42Form 4
Jul 17, 2026ELVNCHIEF MEDICAL OFFICEROpen-market saleCode S · direct2,063$108K@ $52.39Form 4
Jul 17, 2026ELVNCHIEF MEDICAL OFFICEROpen-market saleCode S · direct459$24K@ $51.55Form 4
Jul 17, 2026ELVNCHIEF MEDICAL OFFICEROpen-market saleCode S · direct231$12K@ $50.05Form 4
Jul 17, 2026ELVNCHIEF MEDICAL OFFICEROption exerciseCode M · direct5,000$12K@ $2.48Form 4
Jun 17, 2026ELVNCHIEF MEDICAL OFFICEROpen-market saleCode S · direct1,133$51K@ $44.74Form 4
Jun 17, 2026ELVNCHIEF MEDICAL OFFICEROpen-market saleCode S · direct2,599$114K@ $43.87Form 4
Jun 17, 2026ELVNCHIEF MEDICAL OFFICEROpen-market saleCode S · direct1,268$54K@ $42.83Form 4
Jun 17, 2026ELVNCHIEF MEDICAL OFFICEROption exerciseCode M · direct5,000$12K@ $2.48Form 4
Jun 4, 2026KURAGrant or awardCode A · direct35,000—Form 4
May 18, 2026ELVNCHIEF MEDICAL OFFICEROpen-market saleCode S · direct223$9K@ $41.21Form 4
May 18, 2026ELVNCHIEF MEDICAL OFFICEROpen-market saleCode S · direct1,302$52K@ $40.25Form 4
May 18, 2026ELVNCHIEF MEDICAL OFFICEROpen-market saleCode S · direct3,475$137K@ $39.53Form 4
May 18, 2026ELVNCHIEF MEDICAL OFFICEROption exerciseCode M · direct5,000$12K@ $2.48Form 4
Apr 17, 2026ELVNCHIEF MEDICAL OFFICEROpen-market saleCode S · direct2,441$117K@ $48.06Form 4
Apr 17, 2026ELVNCHIEF MEDICAL OFFICEROpen-market saleCode S · direct2,419$115K@ $47.39Form 4
Apr 17, 2026ELVNCHIEF MEDICAL OFFICEROpen-market saleCode S · direct140$6K@ $45.81Form 4
Apr 17, 2026ELVNCHIEF MEDICAL OFFICEROption exerciseCode M · direct5,000$12K@ $2.48Form 4
Mar 25, 2026ELVNCHIEF MEDICAL OFFICEROption exerciseCode M · direct40,000$99K@ $2.48Form 4
Mar 17, 2026ELVNCHIEF MEDICAL OFFICEROption exerciseCode M · direct5,000$12K@ $2.48Form 4
Mar 10, 2026ELVNCHIEF MEDICAL OFFICEROption exerciseCode M · direct10,129$25K@ $2.48Form 4
Mar 9, 2026ELVNCHIEF MEDICAL OFFICEROption exerciseCode M · direct29,871$74K@ $2.48Form 4
Feb 17, 2026ELVNCHIEF MEDICAL OFFICEROption exerciseCode M · direct45,000$112K@ $2.48Form 4
Feb 12, 2026ELVNCHIEF MEDICAL OFFICERGrant or awardCode A · direct150,000—Form 4
Feb 12, 2026ELVNCHIEF MEDICAL OFFICERGrant or awardCode A · direct25,000—Form 4

How this page is built

Every row comes from a Form 4 filed with the SEC, which officers, directors and holders of more than 10% of a company’s stock must file within two business days of a trade. Transactions are grouped by the reporting owner’s name as filed (spacing, capitals and punctuation ignored); two different people filing under an identical name would appear together, and one person filing under two spellings appears on two pages.

Open-market totals count code P purchases and code S sales over the last 24 months. The same trade reported on more than one filing is counted once; when another owner (for example a fund and its general partner) reports the identical trade, they are listed beside it. Holdings are the shares owned after the latest purchase, sale, gift or tax-withholding line, shown separately for direct and indirect ownership; an indirect figure is one holding line, not a total across every trust or entity.

This page describes what was filed with the SEC; it is not investment advice or a recommendation to buy or sell any security.